Document:

Exhibit 10.4

 

SPONSOR LETTER AGREEMENT

 

This SPONSOR LETTER
AGREEMENT (this “Agreement”), dated as of February 18, 2021, is made by and among HighCape Capital Acquisition
LLC, a Delaware Limited Liability Company (“Sponsor”), a holder of HighCape Class B Common Stock, the
Other Class B Stockholders that are signatories hereto and Deerfield Partners, L.P. (“Deerfield”) (Sponsor,
each of the Other Class B Stockholders that are signatories hereto and Deerfield, each, a “HighCape Shareholder”,
and collectively, the “HighCape Shareholders”), HighCape Capital Acquisition Corp., a Delaware corporation
(“HighCape”) and Quantum-Si Incorporated, a Delaware corporation (the “Company”). The
HighCape Shareholders, HighCape and the Company shall be referred to herein from time to time collectively as the “Parties”.
Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Business Combination
Agreement (as defined below).

 

WHEREAS, HighCape,
the Company and certain other Persons party thereto entered into that certain Business Combination Agreement, dated as of the
date hereof, in substantially the form last provided to Deerfield prior to the date hereof, (as it may be amended, restated or
otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement”);
and

 

WHEREAS, each HighCape
Shareholder is the record and beneficial owner of the number of shares of HighCape Class A Common Stock and/or shares of
HighCape Class B Common Stock set forth on the signature page hereto (together with any other Equity Securities of HighCape
that such HighCape Shareholder holds of record or beneficially, as of the date of this Agreement, or acquires record or beneficial
ownership of after the date hereof, collectively, the “Subject HighCape Equity Securities”); and

 

WHEREAS, the HighCape
Shareholders acknowledge and agree that the Company would not have entered into and agreed to consummate the transactions contemplated
by the Business Combination Agreement without the HighCape Shareholders entering into this Agreement and agreeing to be bound
by the agreements, covenants and obligations contained in this Agreement.

 

NOW, THEREFORE, in
consideration of the premises and the mutual promises contained herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:

 

1.            Agreement
to Vote; Other Covenants.

 

a.            The
HighCape Shareholders (severally and not jointly) hereby agree to vote at any meeting of the stockholders of HighCape, and in
any action by written consent of the stockholders of HighCape, all of such HighCape Shareholders’ Subject HighCape Equity
Securities in favor of the Transaction Proposals.

 

b.           The
HighCape Shareholders shall be (severally and not jointly) bound by and subject to (i) Section 5.3 (Confidentiality)
and Section 5.4(a) (Public Announcements) of the Business Combination Agreement to the same extent as such provisions
apply to the parties to the Business Combination Agreement, as if the HighCape Shareholders were directly party thereto (provided
that Deerfield shall not be bound by or subject to Section 5.3 (Confidentiality) and Sponsor shall be responsible
for any breach of the Confidentiality Agreement caused by any act or omission by Deerfield), and (ii) the first sentence
of Section 5.6(b) (Exclusive Dealing) of the Business Combination Agreement to the same extent as such provisions
apply to HighCape, as if the HighCape Shareholders were directly party thereto.

 

     

     

    

 

c.           The
HighCape Shareholders that are holders of HighCape Class B Common Stock hereby (severally and not jointly) waive any adjustment
to the conversion ratio set forth in the Governing Documents of HighCape or any other anti-dilution or similar protection with
respect to the HighCape Class B Common Stock (whether resulting from the transaction contemplated by the Business Combination
Agreement, the Subscription Agreements, the Anchor Subscription Agreement or otherwise).

 

2.            No
Redemption. The HighCape Shareholders (severally and not jointly) hereby agree that they shall not redeem, or submit a request
to HighCape’s transfer agent or otherwise exercise any right to redeem, any Subject HighCape Equity Securities in connection
with the Business Combination Agreement.

 

3.            Transfer
of Shares. Except as provided in Section 4, the HighCape Shareholders (severally and not jointly) hereby agree
not to, directly or indirectly, during the term of this Agreement, (i) sell, assign, transfer (including by operation of
law), place a lien on, pledge, dispose of or otherwise encumber any of their respective Subject HighCape Equity Securities owned
as of the date hereof and set forth on the signature page hereto (the “Lockup Equity Securities”) or otherwise
agree to do any of the foregoing (each, a “Transfer”), (ii) deposit any of their respective Lockup Equity
Securities into a voting trust or enter into a voting agreement or arrangement or grant any proxy or power of attorney with respect
to any of their respective Lockup Equity Securities that conflicts with any of the covenants or agreements set forth in this Agreement,
(iii) enter into any contract, option or other arrangement or undertaking with respect to the direct or indirect acquisition
or sale, assignment, transfer (including by operation of law) or other disposition of any of their respective Lockup Equity Securities,
(iv) engage in any hedging or other transaction which is designed to, or which would (either alone or in connection with
one or more events, developments or circumstances (including the satisfaction or waiver of any conditions precedent)), lead to
or result in a sale or disposition of their respective Lockup Equity Securities even if such Lockup Equity Securities would be
disposed of by a person other than the HighCape Shareholder or (v) take any action that would have the effect of preventing
or materially delaying the performance of its obligations hereunder. For the avoidance of doubt, none of the restrictions set
forth in this paragraph shall apply to: (i) any HighCape securities purchased by Deerfield in the open market or in any public
or private capital raising transaction of HighCape or otherwise, including, without limitation, any shares of HighCape Class A
Common Stock issued pursuant to the Business Combination Agreement, any subscription agreement or otherwise other than the Lockup
Equity Securities. Notwithstanding the foregoing, Deerfield may sell or otherwise transfer Lockup Equity Securities during its
existence (a) to its managers, partners, members or other direct or indirect equity holders or to any of its other affiliates
or any subsidiary, employee, officer, director, investment fund controlled or managed by Deerfield or its affiliates, or commonly
controlled or managed investment fund or (b) to a charitable foundation controlled by Deerfield, its affiliates, partners,
members or other direct or indirect equityholders or any of their respective immediate family members; provided, however, that
in each such case, any such sale or transfer shall be conditioned upon entry by such transferees into a written agreement, addressed
to HighCape and the Company, agreeing to be bound by these transfer restrictions and the other terms and conditions of this Agreement;
and provided, further, for the avoidance of doubt, that nothing contained herein shall limit or restrict the admission of new
managers, partners, members or other direct or indirect equityholders in, or the increase or decrease in the ownership interests
of any managers, partners, members or other direct or indirect equity holders of, any entity holding any of the other than the
Lockup Equity Securities Equity Securities.

 

    	 	2	 

     

    

 

4.            Forfeiture.
As of immediately prior to, and subject to the consummation of, the Closing, 696,250 shares of HighCape Class B Common Stock
shall be automatically and irrevocably forfeited by the Sponsor to HighCape for no consideration and automatically cancelled.

 

5.            HighCape
Shareholders Representations and Warranties. Each HighCape Shareholder represents and warrants to the Company (severally and
not jointly each with respect to it/him/her self) as follows:

 

a.          Such
HighCape Shareholder, if an entity, is a corporation, limited liability company or other applicable business entity duly organized
or formed, as applicable, validly existing and in good standing (or the equivalent thereof, if applicable, in each case, with
respect to the jurisdictions that recognize the concept of good standing or any equivalent thereof) under the Laws of its jurisdiction
of formation or organization (as applicable).

 

b.          Such
HighCape Shareholder has the requisite corporate, limited liability company, legal capacity or other similar power and authority
to execute and deliver this Agreement, to perform its covenants, agreements and obligations hereunder. The execution and delivery
of this Agreement has been duly authorized by all necessary corporate (or other similar) action on the part of such HighCape Shareholder
that is not a natural person. This Agreement has been duly and validly executed and delivered by such HighCape Shareholder and
constitutes a valid, legal and binding agreement of such HighCape Shareholder (assuming that this Agreement is duly authorized,
executed and delivered by the Company), enforceable against such HighCape Shareholder in accordance with its terms (subject to
applicable bankruptcy, insolvency, reorganization, moratorium or other Laws affecting generally the enforcement of creditors’
rights and subject to general principles of equity).

 

6.            Termination.
This Agreement shall automatically terminate, without any notice or other action by any Party, and be void ab initio upon
the earlier of (a) the Effective Time, (b) the termination of the Business Combination Agreement in accordance with
its terms or (c) upon any amendment, restatement or other modification of Section 2.1 (Closing Transactions),
Section 5.4(a) (Public Announcements), the first sentence of Section 5.6(b) (Exclusive Dealing),
Section 5.8 (HighCape Stockholder Approval), or Section 8.13 (No-Recourse) of the Business Combination
Agreement or any definitions of terms used in such sections, in each case where such amendment, restatement, or other modification
materially and adversely affects Deerfield. Upon termination of this Agreement as provided in the immediately preceding sentence,
none of the Parties shall have any further obligations or Liabilities under, or with respect to, this Agreement. Notwithstanding
the foregoing or anything to the contrary in this Agreement, the termination of this Agreement pursuant to Section 6(b) shall
not affect any Liability on the part of any Party for a willful breach of any covenant or agreement set forth in this Agreement
prior to such termination.

 

    	 	3	 

     

    

 

7.            No
Third Party Beneficiaries. This Agreement shall be for the sole benefit of the Parties and their respective successors and
permitted assigns and is not intended, nor shall be construed, to give any Person, other than the Parties and their respective
successors and assigns, any legal or equitable right, benefit or remedy of any nature whatsoever by reason of this Agreement.
Nothing in this Agreement, expressed or implied, is intended to or shall constitute the Parties as partners or participants in
a joint venture.

 

8.            Incorporation
by Reference. Sections 8.5 (Governing Law), 8.7 (Construction; Interpretation), 8.10 (Severability),
8.11 (Counterparts; Electronic Signatures), 8.15 (Waiver of Jury Trial), 8.16 (Submission to Jurisdiction)
and 8.17 (Remedies) of the Business Combination Agreement are incorporated herein and shall apply to this Agreement mutatis
mutandis.

 

9.            Amendment.
This Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular
provision, except by a written instrument executed by all Parties hereto.

 

10.            Assignment.
No Party hereto may assign either this Agreement or any of its rights, interests, or obligations hereunder without the prior written
consent of the other Parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall
not operate to transfer or assign any interest or title to the purported assignee. This Agreement shall be binding on the undersigned
and its successors and assigns.

 

11.            Non-Survival.
Each of the representations and warranties, and each of the agreements and covenants of the Parties set forth in this Agreement,
shall terminate upon termination of this Agreement, such that no claim for breach of any such representation, warranty, agreement
or covenant, detrimental reliance or other right or remedy (whether in contract, in tort, at law, in equity or otherwise) may
be brought with respect thereto after the termination hereof against any Party.

 

    	 	4	 

     

    

 

IN WITNESS WHEREOF,
each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

 

	 	QUANTUM-SI INCORPORATED
	 	 
	 	By:	/s/ Jonathan M. Rothberg
	 	Name:	Jonathan M. Rothberg, Ph.D
	 	Title:	Executive Chairman

 

[Signature Page to Sponsor Letter
Agreement]

 

     

     

    

 

IN WITNESS WHEREOF,
each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

 

	 	HIGHCAPE CAPITAL ACQUISITION LLC
	 	 
	 	By:	/s/ Kevin Rakin
	 	Name:	 Kevin Rakin
	 	Title:	Chairman and CEO

 

[Signature Page to Sponsor Letter
Agreement]

 

     

     

    

 

IN WITNESS WHEREOF,
each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

 

	 	HIGHCAPE SHAREHOLDER:
	 	 	 
	 	 	 
	 	HIGHCAPE CAPITAL ACQUISITION LLC
	 	 
	 	By:	/s/ Kevin Rakin 
	 	Name:	Kevin Rakin 
	 	Title:	Chairman and CEO
	 	 	 
	 	HighCape Class A Common Stock: 405,000
	 	 	 
	 	HighCape Class B Common Stock: 2,785,000

 

[Signature Page to
Sponsor Letter Agreement]

 

     

     

    

 

IN WITNESS WHEREOF,
each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

 

	 	HIGHCAPE SHAREHOLDER:
	 	 
	 	/s/ David Colpman
	 	David Colpman
	 	 
	 	HighCape Class A Common Stock:    _____
	 	 
	 	HighCape Class B Common Stock: 30,000

 

[Signature Page to Sponsor Letter
Agreement]

 

     

     

    

 

IN WITNESS WHEREOF,
each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

 

	 	HIGHCAPE SHAREHOLDER:
	 	 
	 	/s/ Anthony Loebel, M.D.
	 	Anthony Loebel, M.D.
	 	 
	 	HighCape Class A Common Stock:    _____
	 	 
	 	HighCape Class B Common Stock: 30,000

 

[Signature Page to Sponsor Letter
Agreement]

 

     

     

    

 

IN WITNESS WHEREOF,
each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

 

	 	HIGHCAPE SHAREHOLDER:
	 	 
	 	/s/ Robert Taub
	 	Robert Taub
	 	 
	 	HighCape Class A Common Stock:    ______
	 	 
	 	HighCape Class B Common Stock: 30,000

 

[Signature Page to Sponsor Letter
Agreement]

 

     

     

    

 

IN WITNESS WHEREOF,
each of the Parties has caused this Agreement to be duly executed on its behalf as of the day and year first above written.

 

	 	HIGHCAPE SHAREHOLDER:
	 	 	 
	 	 	 
	 	DEERFIELD PARTNERS, L.P.
	 	By: Deerfield Mgmt, L.P., General Partner
	 	By: J.E. Flynn Capital IV, LLC, General Partner
	 	 	 
	 	By:	/s/ David J. Clark 
	 	Name:	David J. Clark 
	 	Title:	Authorized Signatory
	 	 	 
	 	HighCape Class A Common Stock: 1,000,000
	 	 	 
	 	HighCape Class B Common Stock:    ______

 

[Signature Page to Sponsor Letter
Agreement]Exhibit 10.1

    

    

    Certain confidential information contained in this document, marked by brackets and asterisk, has been 

    omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be 

    competitively harmful if publicly disclosed.

     

    LETTER OF AGREEMENT

     

    This Letter of Agreement (“LOA”) is made and entered into as of this 11th day of July 2013 (“Effective Date”) between Argo Medical Technologies Ltd, an Israeli corporation having its principal place of business at Cohav Yokneam Building, Yokneam Ilit P.O.B 161, Israel 20692 (“Customer”) and
      Sanmina Corporation and its subsidiaries, (collectively “Sanmina”), a Delaware corporation having its principal place of business at 2700 North First Street, San Jose,
      California 95134.

     

    1. Customer and Sanmina are establishing a business relationship under which Customer may, among other things, have Sanmina procure components, parts, and raw material (collectively “Components”)
      to manufacture, assemble, test, inspect configure and ship products detailed in documentation provided by Customer to Sanmina from time to time (“Products”) in accordance with Customer’s purchase orders (“Orders”) submitted by Customer from time to time and accepted by Sanmina. The unit prices for the Products (“Prices”) and the related financial liability for the procurement
      of Components for such Products (“Component Liability”) are as demonstrated in Appendix A hereto, as may be amended in writing by mutual consent of the parties
      from time to time. This LOA is for the purpose of authorizing Sanmina to begin work immediately in lieu of a fully negotiated manufacturing services agreement (“MSA”). This LOA implies no commitment to enter
      into a MSA. Both parties acknowledge that the execution of a MSA is contingent upon the mutual consent of the parties, and that should the MSA not be executed, the terms of this LOA shall be the sole governing agreement until terminated by either
      party. The parties agree that all Orders accepted by Sanmina shall be based on the terms contained in this LOA, unless replaced by a MSA. Customer shall provide Sanmina’s Credit Department upon request a completed credit application. Sanmina shall
      provide Customer with an initial credit limit, which shall be reviewed (and, if necessary, adjusted) from time to time with periodic financial updates from Customer in order to maintain a credit limit. The credit limit may be reduced upon five (5)
      days’ prior written notice to Customer. In the event Customer exceeds its credit limit, Sanmina shall have the right to stop shipments of Product and stop loading new Orders and Forecasts until Customer makes a sufficient payment to bring its account
      within the credit limit provided.

     

    2. Prices are in U.S. Dollars and are subject to change by mutual consent. Prices were agreed by the parties based on (i) the specifications, (ii) the projected volumes and run rates and other assumptions agreed by the
      parties and (iii) shipment FCA Sanmina’s facility of manufacture (Incoterms 2010). Prices specifically exclude (1) export licensing of the Product and payment of broker’s fees, duties, tariffs or other similar charges, (2) taxes (other than those
      based on the net income of Sanmina); and (3) tooling or non-recurring expenses. Payment terms for Products are net thirty (30) days after the date of the invoice which shall not be issued prior to shipment of such Product, provided that if Customer has no credit from Sanmina, such payment shall be made upon shipment (but subject always to receipt of
      invoice). Customer shall pay Sanmina in advance for its Component Liability and Customer acknowledges that Sanmina will not place any orders for Components until such time as Sanmina has received the advance payment in full from Customer to cover its
      Component Liability. It is clarified that Component Liability pre-paid by Customer for any Product shall be deducted from the Price payable for such Product.

     

    3. Customer may also provide Sanmina with forecasts for future requirements of Products (“Forecasts”). Provided that Sanmina has received an advanced payment from Customer to cover
      its Component Liability in full, Sanmina will procure the quantity and type of Components necessary to manufacture the quantities of Product set forth in the Order and Forecast in accordance with its standard material ordering policies available at www.sanmina-sci.com
      (“Policies”), and agrees to be financially responsible for all Components ordered in accordance with the Policies. Customer guarantees the obligations of each of its subsidiaries or affiliates that places
      Orders or Forecasts pursuant to this LOA, and agrees to be jointly liable for all such obligations.

    

    

    4. Sanmina warrants that, for a period of one year from the date of manufacture of the Product, the Product will be free from defects in workmanship. Products shall be considered free from defects in workmanship if they
      are manufactured in accordance with the most current version of IPC-A-600 or IPC-A-610. Sanmina shall, at its option and at its expense (and as Customer’s sole and exclusive remedy for breach of any warranty), repair, replace or issue a credit for
      Product found to have defective workmanship during the warranty period. In addition, Sanmina will administer and pass through to Customer (to the extent that they are transferable) manufacturers’ Component warranties and manage such warranties on
      Customer’s behalf, but does not independently warrant Components. THE SOLE REMEDY UNDER THIS WARRANTY SHALL BE THE REPAIR, REPLACEMENT, OR CREDIT FOR DEFECTS AS STATED ABOVE. THIS WARRANTY IS THE SOLE WARRANTY GIVEN BY SANMINA AND IS IN LIEU OF ANY
      OTHER WARRANTIES EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, NON INFRINGEMENT, AND FITNESS FOR A PARTICULAR PURPOSE, EACH OF WHICH IS SPECIFICALLY DISCLAIMED. Compliance with “RoHS”, “REACH” and other
      environmental legislation worldwide shall be as separately agreed by the parties.

    
      
        

    

    
     

    5. Customer may terminate this LOA or cancel an Order hereunder upon written notice to Sanmina. Sanmina will make commercially reasonable efforts to return Components to vendors (provided that Sanmina shall not be so
      obligated for Components which have a line item value of less than $1000). Termination for Cause: either party may terminate this LOA or an Order for default if the other party materially breaches and
      has not cured within thirty (30) days after the defaulting party is notified in writing of the material breach. Cure period for payment-related breaches shall be five (5) business days from receipt of notice. Termination
          Based on other than Sanmina Breach: if this LOA or an Order is terminated by Customer for any reason other than a breach by Sanmina (including but not limited to a force majeure or termination
      for convenience), Customer shall pay Sanmina: (1) the Order price for all finished Product existing at the time of termination; (2) Sanmina’s cost (including labor, Components, and mark-up on Components and labor as set forth in Appendix A
      hereto) for work in process; and (3) Component inventory pursuant to Section 3 above. Termination Based on Sanmina’s Breach: if Customer terminates this LOA or cancels an Order as a result of an uncured
      breach by Sanmina, Customer shall pay (1) the Order price for finished Product at the time of termination; (2) Sanmina’s cost (including labor, Components) for work in process; and (3) Component inventory pursuant to Appendix A hereto and
      Section 3 excluding Sanmina markup or acquisition cost on Components relating to such uncured breach. Sanmina remains liable to Customer for damages pursuant to this LOA. Customer shall be
      responsible for Sanmina’s documented cost to perform Customer-authorized non-recurring engineering or associated program duties. Provided that the Customer has no outstanding receivable, upon termination, Sanmina will deliver to Customer all Products
      and Components. Further, upon termination Sanmina will promptly deliver to Customer any and all documentation and other property owned by Customer or for which Customer has paid under this LOA.

     

    6. IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER FOR ANY INDIRECT, CONSEQUENTIAL, INCIDENTAL, PUNITIVE OR SPECIAL DAMAGES, OR ANY DAMAGES WHATSOEVER RESULTING FROM LOSS OF USE, DATA OR PROFITS, EVEN IF SUCH OTHER
      PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. FOR THE PURPOSE OF THIS SECTION, BOTH LOST PROFITS AND DAMAGES RESULTING FROM VALUE ADDED TO THE PRODUCT BY CUSTOMER SHALL BE CONSIDERED CONSEQUENTIAL DAMAGES. IN NO EVENT SHALL SANMINA’S
      LIABILITY FOR A PRODUCT (WHETHER ASSERTED AS A TORT OR CONTRACT CLAIM) EXCEED THE AMOUNTS PAID TO SANMINA FOR SUCH PRODUCT HEREUNDER. IN NO EVENT SHALL EITHER PARTY’S LIABILITY FOR ALL CLAIMS ARISING OUT OF OR RELATING TO THIS LOA EXCEED THE LESSER
      OF EITHER $[***] OR [***] PERCENT ([***]%) OF THE TRAILING 12 MONTHS OF REVENUE FOR PRODUCT PAID FOR UNDER THIS LOA (THE “CAP”). THESE LIMITATIONS SHALL APPLY NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF
      ANY LIMITED REMEDY. THE CAP SHALL NOT APPLY TO LIMIT (i) CUSTOMER’S OBLIGATIONS HEREUNDER FOR TERMINATION/CANCELLATION PAYMENTS, AND (ii) THERE SHALL BE NO LIMITATIONS UNDER THIS SECTION ON A PARTY’S INDEMNIFICATION OBLIGATIONS. THE LIMITATIONS SET
      FORTH IN THIS SECTION SHALL APPLY WHERE THE DAMAGES ARISE OUT OF OR RELATE TO THIS LOA.

     

    7. Sanmina shall promptly indemnify, defend, and hold Customer and its affiliates, shareholders, directors, officers, employees, contractors, agents, and other representatives harmless from all third party demands,
      claims, actions, causes of action, proceedings, suits, assessments, losses, damages, liabilities, settlements, judgments, fines, penalties, interest, costs and expenses (including fees and disbursements of counsel) of every kind (collectively, “Claim(s)”) (a) based upon personal injury or death or injury to property (other than damage to the Product itself, which is handled in accordance with Sanmina’s warranty) to
      the extent caused by the negligent or willful acts or omissions of Sanmina or its officers, employees, subcontractors or agents and/or (b) arising from or relating to any actual or alleged infringement, misappropriation, or alleged violation of any
      intellectual property rights relating to Sanmina’s manufacturing processes.

    
      2

      
        

    

     

    8. Customer shall promptly indemnify, defend, and hold Sanmina harmless from and against every Claim (a) based upon personal injury or death or injury to property to the extent caused by the negligent or willful acts or
      omissions of Customer or its officers, employees, subcontractors, or agents, (b) arising from or relating to any actual or alleged infringement, misappropriation or alleged violation of any intellectual property rights relating to a Product or
      portion of a Product, or (c) that the Product has a design defect or fails to comply with “RoHS”, “WEEE”, “REACH”’ (or other environmental legislation) where such failure was not the responsibility of Sanmina.

     

    9. The parties hereby agree to amend the Non-Disclosure Agreement (“NDA”) entered into between the parties on April 25, 2013 such that the meaning of “Information” (as defined therein) shall also include (without derogation from any other meaning included therein) any information related to Company’s shareholders (as the terms “Company” is
      defined therein). The NDA (as herein amended) is hereby incorporated herein by reference. A copy of the NDA (prior to the above amendment) is annexed hereto as Appendix B.

     

    10. Any and all intellectual property rights and other rights in and to the Products and its underlying technology, including without limitation any derivatives thereof, and including further any changes or improvements
      therein made following contribution by Sanmina, shall be retained by Customer at all times, and no right therein is granted to Sanmina by virtue of this LOA or otherwise.

     

    11. This LOA and its attachments make up the entire agreement between the parties and supersede prior discussions, except for the NDA incorporated in this LOA (as amended hereby). The parties expressly reject any
      pre-printed terms and conditions of any Order, acknowledgment, or any other form document of either party. The terms hereof may be amended only by a writing executed by authorized representatives of the parties. This LOA will not be assigned by
      either party without the other party’s prior written consent except that subject to Section 3, Customer may assign its rights and obligations hereunder without the need for consent to any affiliate or successor. Customer shall be the exporter of
      record for all Products shipped hereunder, and shall comply with all applicable export control statutes and regulations. This LOA shall be construed in accordance with the substantive laws of California (excluding its conflicts of laws principles).
      The parties acknowledge and agree that the state courts of Santa Clara County or federal courts of the Northern District of California shall have exclusive jurisdiction and venue to adjudicate any and all disputes in connection with this LOA. The
      provisions of the United Nations Conventions on Contracts for the International Sale of Goods shall not apply to this LOA.

     

    ACCEPTED AND AGREED TO:

    	
            SANMINA CORPORATION

          	 	
            CUSTOMER

          
	 	 	 	 
	
            By:

          	 	
            
              /s/ Mark Kraizer

            

          	 	
            By:

          	 	
            
              /s/ Ami Kraft

            

          
	 	 	 	 
	
            Name:

          	 	
            
              Mark Kraizer

            

          	 	
            Name:

          	 	
            
              Ami Kraft

            

          
	 	 	 	 
	
            Title:

          	 	
            
              VP & General Manager

            

          	 	
            Title:

          	 	
            
              CFO

            

          
	 	 	 	 
	 	 	
            Sanmina Israel

          	 	 	 	
            Argo

            Medical Technologies Ltd.

          

    

    

    
      3

      
        

    

    

    

    LOA Appendix A

     

    Pricing

     

    The price model agreed between Sanmina and Argo Medical Technologies is as follows:

     

    [***]

     

    The price model above and the Qty of the system refers to minimum order quantities (“MOQs”) to be agreed by the parties from time to time.

     

    Numerical Examples:

     

    [***]

     

    NRE Charges:

     

    [***]

     

    For extra engineering services Sanmina will charge [***] USD per hour.

     

    Component Liability:

     

    Liability for Components shall be determined between the Parties on a case-by-case basis.

    
      4

      
        

    

     

     

    NDA

    

     

    CONFIDENTIALITY AND NON-DISCLOSURE AGREEMENT

     

    WHEREAS, Argo Medical Technologies Ltd., having an address at Kochav Yokneam Building, POB 161, Yokneam 20692, Israel (hereinafter, together with any affiliate thereof, “Company”),
      possesses confidential and proprietary information, methods and technology in connection with a device and methods for overcoming impeded locomotion disability, and related devices that utilize similar principles and technology (hereinafter “Product”);

     

    WHEREAS, Sanmina- having an address at P.O.B 102 Maa’lot 24952 Israel (hereinafter “Recipient”), desires to provide to the Company certain out sourcing services, as may be agreed
      in writing between the Company and Recipient form time to time (the “Services”); and

     

    WHEREAS, the Company may disclose to Recipient from time to time, at its discretion, certain Information (as defined below) to enable Recipient to provide the Services (the “Purpose”)
      and,;

     

    NOW, THEREFORE, to induce disclosure by the Company of such Information, Recipient hereby undertakes and agrees as follows (the “Undertaking”):

     

    1. The term “Information” means any and all confidential and proprietary information of, or related to, the Company, including but not limited to any and all specifications,
      methods, prototypes, technology (including production technology), computer programs, and any and all records, data, methods, techniques, processes, projections, plans, marketing and/or pricing information, materials, financial statements, memoranda,
      analyses, notes and any other data or information (in whatever form), as well as improvements and know-how related thereto, relating to or concerning the Company, the Company’s suppliers or products, irrespective of form, but shall not include
      information that (i) was already known to or independently developed by the Recipient prior to its disclosure as demonstrated by reasonable and tangible evidence satisfactory to the Company; (ii) shall have appeared in any printed publication or
      patent or shall have become a part of the public knowledge except as a result of breach of this Undertaking by the Recipient; (iii) shall have been received by the Recipient from another person or entity having no obligation to the Company or the
      Company’s suppliers; or (iv) is approved in writing by the Company for release by the Recipient.

     

    2. Recipient (i) shall treat all Information as strictly confidential, (ii) shall not disclose any Information to any other person or entity, other than Recipient’s employees, officers and directors, with a need to know
      who have confidentiality obligations at least as restrictive as those contained herein, without the prior written consent of the Company, (iii) shall protect the Information with at least the same degree of care and confidentiality as it affords its
      own confidential information, at all times exercising at least a high degree of care in such protection, and (iv) shall not use any Information in any manner except for Purpose.

    

    3. The Recipient acknowledges and agrees that the Information is and shall remain proprietary to the Company. All copies of the Information shall be returned to the Company immediately upon request without retaining
      copies thereof.

     

    4. It is understood and agreed that any disclosure of Information shall not grant the Recipient any express, implied or other license or rights to patents or trade secrets of the Company, whether or not patentable, nor
      shall it constitute or be deemed to create a partnership, joint venture or other like engagement. Further, Recipient agrees that it shall not remove or otherwise alter any of the trademarks or service marks, serial numbers, logos, copyrights, notices
      or other proprietary notices, if any, fixed or attached to Information or any part thereof.

    
      5

      
        

    

     

    5. Neither this Undertaking nor the disclosure or receipt of Information shall constitute or imply any promise or intention by Company to receive Services from the Recipient, or any commitment by Company with respect to
      present or future relationship with Recipient.

     

    6. The Recipient’s Undertakings herein shall be binding upon it and its affiliates, subsidiaries or successors and shall continue until permission is specifically granted in writing to the Recipient by the Company to
      release the Information.

     

    7. Recipient acknowledges that violation of its obligations hereunder could cause the Company irreparable harm (including, but not limited to, the loss of patent rights) which could not be reasonably or adequately
      compensated for in damages resulting from an action of law and, therefore, that Recipient’s agreements hereunder shall be enforceable both under law or in equity, by injunction or otherwise, without the necessity of posting a bond.

     

    8. This Undertaking shall be exclusively governed by, construed and enforced in accordance with the laws of the State of Israel, the courts of which shall have exclusive jurisdiction over any dispute hereunder. A
      determination that any term of this Undertaking is void or unenforceable shall not affect the validity or enforceability of any other term or condition and any such invalid provision shall be construed and enforced (to the extent possible) in
      accordance with the original intent of the parties as herein expressed.

     

    IN WITNESS WHEREOF, the Recipient has executed this Undertaking on April 25 , 2013.

    	 	 	 
	
            RECIPIENT

          	 
	 	 	 
	
            By:

          	
            
              /s/ Nir Marko

            

          	 
	 	 	 
	
            Title:

          	
            
              Director Business Development

            

          	 
	 	 	 
	 	
            Sanmina -Sci

          	 

    

    

  

  6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]